| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |